OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
366A$964.0056

Wellness Communications Corp

Healthcare Facilities & ServicesVerified

Wellness Communications Corp maintains a strong liquidity position, with cash and equivalents amounting to ¥2.79 billion, representing 53.9% of total assets. The company's liquidity FPT score is high, supported by a current ratio of 2.37 and free cash flow of ¥763 million. This liquidity position is well above the median for its industry, indicating a robust ability to meet short-term obligations. Profitability metrics show a return on equity (ROE) of 22.45% and a return on assets (ROA) of 14.98%, both significantly above the industry median. The company's operating margin is 7.9%, with a net margin of 5.52%, reflecting efficient cost management and strong pricing power in its health checkup and cloud services. The company's revenue is distributed across three segments: Health Checkup Solutions, Health Management Cloud, and Medical Institution Support. The Health Checkup Solutions segment is the largest contributor, with no specific revenue breakdown provided. However, the company's geographic exposure is concentrated in Japan, with no disclosed international operations, which may limit growth potential. Looking ahead, the company is projected to grow revenue by 5.2% in the current fiscal year and 4.8% in the next, driven by expansion in its SaaS health management cloud offerings. Historical revenue growth has averaged 3.7% annually over the past five years, indicating a stable but moderate growth trajectory. Risk factors are minimal, with low liquidity and dilution risk scores. The company has no long-term debt and a debt-to-equity ratio of 0.0, suggesting a conservative capital structure. No dilution risks were identified in recent filings, and the company has not issued new shares in the past year. Recent events include the continued development of its i-Wellness and Growbase platforms, which are central to its SaaS offerings. The company has also expanded its PET-related services in the Medical Institution Support segment, enhancing its value proposition to healthcare providers.

30-day price · 366A+108.00 (+10.7%)
Low$926.00High$1154.00Close$1118.00As of21 May, 00:00 UTC
Profile
CompanyWellness Communications Corp
Ticker366A.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Wellness Communications Corp provides medical checkup solutions and health management cloud services in Japan, operating through three segments: Health Checkup Solutions, Health Management Cloud, and Medical Institution Support.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Wellness Communications Corp maintains a strong liquidity position, with cash and equivalents amounting to ¥2.79 billion, representing 53.9% of total assets. The company's liquidity FPT score is high, supported by a current ratio of 2.37 and free cash flow of ¥763 million. This liquidity position is well above the median for its industry, indicating a robust ability to meet short-term obligations. Profitability metrics show a return on equity (ROE) of 22.45% and a return on assets (ROA) of 14.98%, both significantly above the industry median. The company's operating margin is 7.9%, with a net margin of 5.52%, reflecting efficient cost management and strong pricing power in its health checkup and cloud services. The company's revenue is distributed across three segments: Health Checkup Solutions, Health Management Cloud, and Medical Institution Support. The Health Checkup Solutions segment is the largest contributor, with no specific revenue breakdown provided. However, the company's geographic exposure is concentrated in Japan, with no disclosed international operations, which may limit growth potential. Looking ahead, the company is projected to grow revenue by 5.2% in the current fiscal year and 4.8% in the next, driven by expansion in its SaaS health management cloud offerings. Historical revenue growth has averaged 3.7% annually over the past five years, indicating a stable but moderate growth trajectory. Risk factors are minimal, with low liquidity and dilution risk scores. The company has no long-term debt and a debt-to-equity ratio of 0.0, suggesting a conservative capital structure. No dilution risks were identified in recent filings, and the company has not issued new shares in the past year. Recent events include the continued development of its i-Wellness and Growbase platforms, which are central to its SaaS offerings. The company has also expanded its PET-related services in the Medical Institution Support segment, enhancing its value proposition to healthcare providers.
Key takeaways
  • Strong liquidity position with cash and equivalents covering 53.9% of total assets.
  • High profitability with ROE of 22.45% and ROA of 14.98%, both above industry medians.
  • Revenue growth is projected at 5.2% for the current fiscal year, driven by SaaS expansion.
  • Low liquidity and dilution risk scores indicate a conservative and stable capital structure.
  • --
  • ## RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$14.06B
Gross profit$2.81B
Operating income$1.11B
Net income$776.2M
R&D
SG&A
D&A
SBC
Operating cash flow$1.69B
CapEx-$269.3M
Free cash flow$762.7M
Total assets$5.18B
Total liabilities$1.73B
Total equity$3.46B
Cash & equivalents$2.79B
Long-term debt$213.0k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$964.00
Market cap$12.01B
Enterprise value$9.23B
P/E15.5
Reported non-GAAP P/E
EV/Revenue0.7
EV/Op income8.3
EV/OCF5.5
P/B3.5
P/Tangible book3.5
Tangible book$3.46B
Net cash$2.79B
Current ratio2.4
Debt/Equity0.0
ROA15.0%
ROE22.4%
Cash conversion2.2%
CapEx/Revenue-1.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
Metric366AActivity
Op margin7.9%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin5.5%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin20.0%28.8% medp25 28.8% · p75 28.8%bottom quartile
CapEx / revenue-1.9%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity0.0%71.3% medp25 60.7% · p75 71.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:07 UTC#eb2ea815
Market quoteclose JPY 964.00 · shares 0.01B diluted
no public URL
2026-05-10 08:07 UTC#61f65e24
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:09 UTCJob: 83641e38